Insmed (INSM) Net Cash Flow (2010 - 2026)

Insmed's Net Cash Flow history runs 17 years deep, the most recent figure standing at $72.3 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 147.35% year-over-year to $72.3 million; the TTM figure through Mar 2026 stood at $179.5 million (up 192.97% YoY), while the FY2025 annual figure was -$45.5 million, down 161.54% from the prior year.
• Net Cash Flow for Q1 2026 stood at $72.3 million, down from $175.7 million in the prior quarter.
• The five-year high for Net Cash Flow was $880.1 million in Q2 2025, with the low at -$948.6 million in Q3 2025.
• The 5-year median for Net Cash Flow is -$5.8 million (2023), against an average of -$7.8 million.
• The sharpest annual moves came in 2023 and 2024: Net Cash Flow slumped 3783.94% in 2023, then soared 1752.77% in 2024.
• Insmed's Net Cash Flow stood at $660.5 million in 2022, then sank by 100.87% to -$5.8 million in 2023, then jumped by 1752.77% to $95.1 million in 2024, then surged by 84.76% to $175.7 million in 2025, then sank by 58.85% to $72.3 million in 2026.
• Business Quant data shows INSM's Net Cash Flow at $72.3 million in Q1 2026, $175.7 million in Q4 2025, and -$948.6 million in Q3 2025.